• Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Bone Marrow
  • Myoglobin, Serum
  • Zaleplon, Urine
  • Fluoxetine, Serum
  • Imipramine, Urine
  • Interferon-γ Receptor (IFNGR1) Deficiency
  • Prolactin
  • Pyruvate Kinase, Erythrocytes
  • Bone Alkaline Phosphatase, Serum
  • Amoebic Serology
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Turnaround Time
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.